... 06 Chairman's Letter 13 / 05 JBCPL Announces Audited Financial Results for FY 2004-05. 02 / 05 JBCPL forays into Kangaroo (Australian) Country 17 / 03 JBCPL's Doktor Mom is Most Trusted European Brand 2005 24 / 02 TGA Australia approves JBCPL's tablets facility at Panoli. 10 / 02 Renowned Intl Cardiologist Dr. Philip A. Poole Wilson Shares Findings Of Trials on Anti-Anginal Drug 27 / 01 JBCPL reports increase in turnover and Net Profit for the Q3 ended December 31, 2004 08 / 12 US FDA accepts JBCPL's DMF API for Ciprofloxacin Hydrochloride 08 / 11 JBCPL launches Magnilek, a MRI CONTRAST media, expanding its High-Tech Diagnostic Product Range 03 / 11 JBCPL To Foray Into Biotechnology 29 / 10 JBCPL announces Q2 RESULTS 28 / 09 JBCPL appoints Mr. Jay Mehta as Vice President, R & D 13 / 09 JBCPL announces maiden US FDA approval to market ciprofloxacin tablets in the US market 26 / 08 MHRA, UK approves JBCPL's Tablets Manufacturing Facility at Panoli. 28 / 07 JBCPL reports increase in Net Sales and PAT for Q1 ended June 30, 2004. ...

... Zoledronic Acid Injection. 11 / 24 / 2008 PharmaForce Receives FDA Approval for Methylergonovine Maleate Injection, USP PharmaForce, Inc. today received FDA approval for Methylergonovine Maleate Injection, USP. The drug is a new generic available in the U.S. 7 / 25 / 2008 PharmaForce Receives FDA Approval for Pamidronate Disodium Injection 3 mg / ml and 9 mg / ml PharmaForce, Inc. today received FDA approval for Pamidronate Disodium Injection 3 mg / ml and 9 mg / ml. 1 / 16 / 2008 PharmaForce Receives FDA Approval for Ciprofloxacin Ophthalmic Solution, USP PharmaForce, Inc. today received FDA approval for Ciprofloxacin Ophthalmic Solution, USP. 12 / 14 / 2007 PharmaForce Receives FDA Approval for Fomepizole Injection PharmaForce, Inc. today received FDA approval for Fomepizole Injection. The drug is a new generic available in the U.S. 12 / 3 / 2007 PharmaForce Receives FDA Approval for Phenytoin Sodium Injection, USP PharmaForce, Inc. today received FDA approval for Phenytoin Sodium Injection, USP. 10 / 18 / 2007 PharmaForce Ranked Twelfth Fastest Growing Privately Held Company in Central Ohio ...

... Home Contact us Press Room Aurobindo's Q1 Net Profit up by 61.7 %Approval received from US FDA for Amlodipine Besylate Tablets Received 46th ANDA approval from US FDA for Terbinafine HCL Tablets Aurobindo records revenues of Rs.23 billions with multifold growth in earnings Aurobindo receives Tentative approval for Quinapril Hydrochloride and Hydrochlorothiazide Tablets from USFDA Aurobindo received Zidovudine approval from MCC South Africa Aurobindo gets USFDA Approval for Trandolapril Tablets Aurobindo receives USFDA Approval for Cefpodoxime proxetil Tablets Aurobindo Pharma Unveils New Corporate Identity Aurobindo receives USFDA Approval for its Ciprofloxacin Aurobindo gets USFDA Approval for its Cefprozil Tablets Aurobindo receives USFDA Approval for its Zolpidem Aurobindo receives ninth approval from MCC South Africa Aurobindo receives Eighth approval from MCC South Africa MEB Netherlands approves Lisinopril Tablets of Aurobindo Cephazone, cephalosporin sterile injectable facility in California, is approved by US FDA and receives approval of Ceftriaxone from US FDA Aurobindo receives US FDA Final approval For Didanosine Oral Suspension Aurobindo receives NAM Finland Approval for its facility at UNIT-VI Aurobindo ’ s debut in Botswana is with 9 products in one go Seventh approval from MCC South Africa Aurobindo ’ s tally of USFDA approved cephs ...